Move over gold: Could ASX 200 healthcare shares be the new 'safe-haven' investments?

Why healthcare shares have been healthier for the portfolio than gold miners.

When markets turn sour, investors tend to flock towards 'safe-haven' assets in an attempt to preserve wealth. In the past, gold has been the go-to during these times of instability.

Yet, if the past year has been anything to go by, perhaps healthcare shares included in the S&P/ASX 200 Index (ASX: XJO) are the new 'gold standard'.

Health workers shake hands and congratulate each other on good news.

Image source: Getty Images

Seeking out healthier returns than the ASX 200

Historically, the eye-catching yellow metal has delivered superior returns throughout periods of high inflation.

According to a recent article from Australian Resources and Investment, the price of gold rose an average of 14% when inflation was above 3%. Similarly, the precious metal achieved returns of almost 25% (on average) during bouts of inflation averaging above 5%.

That would lead investors to believe that gold exposure would be ideal amid the highest annual inflation we have seen in decades.

However, the price of gold per ounce has moved nearly 7% downward compared to a year ago.

Furthermore, the lack of protection extends over to ASX-listed gold mining shares. Even the biggest of the big have suffered tremendously in the last 12 months.

As shown below, the likes of Northern Star Resources Ltd (ASX: NST), Newcrest Mining Ltd (ASX: NCM), and Evolution Mining Ltd (ASX: EVN) have cratered 28.5%, 37.8%, and 55.6%, respectively. Whereas, a handful of ASX 200 healthcare shares have managed to hold up better and, in some cases, outperform.

TradingView Chart

While the returns might still be negative, the point is the reduced downside. Investments in Cochlear Limited (ASX: COH), ResMed Inc (ASX: RMD), and CSL Limited (ASX: CSL) have resulted in more modest falls of 18.6%, 6.3%, and 2.8%, respectively.

Yesterday, Janus Henderson portfolio manager Andy Acker highlighted some attractive traits of healthcare companies.

With interest rates expected to keep rising and economic growth potentially slowing, the pricing power and non-cyclicality of areas such as pharmaceuticals and managed care could continue to stand out.

Is there still value in gold as a hedge?

Despite the lacklustre performance of gold and gold mining shares, could there still be a case for holding these 'traditionally' inflation-hedged assets?

Firstly, the precious metal may have yielded a negative return in the last year. However, as demonstrated in the chart below, it has still outperformed the ASX 200 index. That alone could be justification that gold still has its protective properties.

TradingView Chart

For now, investors of gold mining shares will be hoping their luck soon turns. These companies are currently struggling with a double whammy. Simultaneously, gold prices are falling while input costs — such as labour and materials — are increasing.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd., Cochlear Ltd., and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

An older woman tries to listen by cupping her ear.
Healthcare Shares

Cochlear shares jump 9% in a week: Can they break past $150?

The shares are climbing higher into the green again on Wednesday.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Sigma Healthcare provides Chemist Warehouse sales update

Sigma Healthcare is in focus following strong double-digit Chemist Warehouse sales growth locally and overseas.

Read more »

Happy doctor using her laptop.
Healthcare Shares

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

Telix Pharmaceuticals' Q3 2026 update sees strong revenue growth, FDA milestones, and a major merger to expand its radiopharmaceuticals platform.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Opinions

CSL shares: I weighed up the bull and bear case, and here's my final verdict

The ASX biotech company has rebounded strongly from a multi-year low in June.

Read more »

A silhouette shot of two business man shake hands in a boardroom setting with light coming from full length glass windows beyond them.
Healthcare Shares

Pro Medicus: $43m US contract boosts outlook

Pro Medicus announces a $43m, 7-year US hospital imaging contract.

Read more »

Three healthcare workers standing together and smiling.
Healthcare Shares

Pro Medicus signs A$24M US deal

Pro Medicus shares are in the spotlight after announcing a major US contract win for its Visage cloud imaging platform.

Read more »

Two pharmacist talking to each other.
Healthcare Shares

How much could the Sigma Healthcare share price rise in the next year?

Could this stock deliver healthy returns?

Read more »

A business man wearing a life jacket prepares to jump off a sinking boat
ASX Share Market News

ASX 200 utilities and healthcare shares win the week again

This is the second week in which these traditionally defensive market sectors outperformed.

Read more »